Name | Type | Posted | Actions |
|---|---|---|---|
Amendment_5to_the_RFP_-_10-18-2024_0005.pdf | Oct 18, 2024 | ||
Amendment_4_to_the_RFP_-_10-11-2024_0004.pdf | Oct 11, 2024 | ||
Amendment_3_to_the_RFP_-_10-08-2024_0003.pdf | Oct 8, 2024 | ||
Amendment_2_to_the_RFP_-_9-20-24_0002.pdf | Sep 20, 2024 | ||
Amendment_1_to_RFP_75N94024R00008_9-11-24_0001.pdf | Sep 11, 2024 | ||
Sol_75N94024R00008.pdf | Sep 4, 2024 |
A--BPCA Pediatric Trials Network
A--BPCA Pediatric Trials Network
Contact and place of performance
OSINSKI, ELIZABETH J
Not specified
Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)
The National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) is soliciting proposals for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN). This initiative focuses on health research and development services and basic research, as categorized under PSC code AN11, HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH. The project falls under NAICS code 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The solicitation, identified by number 75N94024R00008, requires responses by the deadline of November 4, 2024. Elizabeth J. Osinski is the designated point of contact for this requirement. The formal documentation for this opportunity consists of the original request for proposals and five subsequent amendments released between September 11, 2024, and October 18, 2024.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.